Incruse Ellipta (Umeclidinium Bromide)

Type

Product

Manufacturer

Country

Dosage

Qty-Price (USD)

Type:

Product: Incruse Ellipta Inhaler (Equavlent to 62.5 mcg)

Manufacturer: GSK

Country: United Kingdom

Dosage: 55 mcg/30 dose

Qty-Price (USD):

Type:

Product: Incruse Ellipta Inhaler

Manufacturer: GSK

Country: Canada

Dosage: 62.5 mcg/30 dose

Qty-Price (USD):

Generic Equivalent of Incruse Ellipta

Type

Product

Manufacturer

Country

Dosage

Qty-Price (USD)

There is no generic product of Incruse Ellipta.

Incruse Ellipta online Canadian Pharmacy

Incruse Ellipta Information

medically reviewed by Dr. HaVy Ngo, Pharmacist on June 13, 2025.

Incruse Ellipta at CanadaPharmacyOnline.com

Brand Incruse Ellipta, manufactured by GSK, is available in Canada and the United Kingdom.

Generic umeclidium bromide is currently unavailable (at this pharmacy).

Dosage:

Incruse Ellipta, a dry powder for inhalation, is available in 62.5 mcg per actuation (dose), and typically comes in a standard package of a 30-dose inhaler in the Canadian market. It is also equivalent to 55 mcg in the UK.

Your doctor will determine the appropriate dose based on your needs and medical condition.

Usage:

Incruse Ellipta is a prescription medication that prevents and controls symptoms such as shortness of breath and wheezing in adults with chronic obstructive pulmonary disease (COPD) (bronchitis and emphysema).

For more information, refer to the product labeling information: https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/205382s002lbl.pdf.

Mechanism of Action:
Incruse Ellipta works by helping to open the airways in your lungs, making it easier to breathe. Its active ingredient, umeclidinium, belongs to a group of medicines called anticholinergics (also known as long-acting muscarinic antagonists or LAMAs). When you breathe, tiny muscles around your airways can sometimes tighten, especially in conditions like COPD. This tightening narrows the airways, making it hard for air to get in and out. Umeclidinium works by blocking specific signals in these muscles that tell them to tighten. By blocking these signals, Incruse Ellipta helps the muscles in your airways relax and stay open.

This allows more air to flow in and out of your lungs, which reduces symptoms like shortness of breath, wheezing, and coughing, helping you breathe more easily throughout the day. It's a "maintenance" treatment, meaning it works over time to keep your airways open, and is not for sudden breathing problems.

Use Incruse Ellipta exactly as your doctor prescribes. Do not change your dosage or stop using the medication without consulting your doctor. Follow the instructions in the product monograph in Canada: https://pdf.hres.ca/dpd_pm/00040519.PDF.

The information below summarizes some, but not all, potential side effects, risks, and interactions. Before taking Incruse Ellipta, it is essential to discuss all possible aspects with your doctor or pharmacist.

Side Effects:

Below is a partial list of side effects; individual reactions can vary. Before starting Incruse Ellipta, it is crucial to discuss potential side effects and risks with your doctor and pharmacist.

Common side effects: These are examples of some common side effects of Incruse Ellipta, but others are possible. Contact your doctor promptly if any side effects are persistent, worsening, or concerning, or if you experience any other concerning symptoms.
• Back pain, joint pain, muscle pain
• Bruising
• Constipation
• Cough
• Dizziness
• Dry mouth
• Fast or irregular heartbeat (tachycardia)
• Headache
• Hoarseness, mouth, and throat pain
• Nasopharyngitis (inflammation of the nose and throat)
• Sinusitis (inflammation of the sinuses, often with pressure or pain in the cheeks and forehead)
• Stomach or abdominal pain
• Taste disturbance
• Upper respiratory tract infection (e.g., stuffy or runny nose, sore throat, cough, common cold symptoms)
• Urinary tract infection (UTI) (e.g., painful and frequent urination)

Serious or rare side effects: Stop taking Incruse Ellipta and seek immediate medical attention if you experience any of the following
• Heart problems: While a faster heartbeat can be common, any new or worsening irregular heartbeat, chest pain, or significant changes in heart rate should be reported to your doctor.
• New or Worsening Eye Problems (Acute Narrow-Angle Glaucoma): Symptoms can include eye pain or discomfort, blurred vision, seeing halos or bright colors around lights, and red eyes.
• Serious Allergic Reactions (Anaphylaxis/Angioedema): Symptoms may include hives, rash, severe itching, swelling of your face, lips, tongue, or throat, and difficulty breathing.
• Sudden breathing problems or worsening of wheezing immediately after inhaling Incruse Ellipta (paradoxical bronchospasm). This is rare but can be life-threatening. Stop using the inhaler and seek emergency medical help.
• Urinary Retention: Symptoms may include difficulty urinating, painful urination, frequent urination, or urinating in a weak stream or drips. This is especially important for people with an enlarged prostate or other bladder issues.

Contraindications:

This is not an exhaustive list of contraindications. It is crucial to discuss all your medical conditions, past and present, and all medications you are taking with your doctor or pharmacist before starting Incruse Ellipta.

Incruse Ellipta should not be used if:
• Hypersensitivity to Umeclidinium or Any Other Ingredient (Excipients): If you have a known allergy to the active ingredient umeclidinium or any of the other inactive ingredients (excipients) in Incruse Ellipta, you should not use it.
• Severe Hypersensitivity to Milk Proteins: Incruse Ellipta is a dry powder inhaler that contains lactose, which is derived from milk. If you have a severe allergy to milk proteins, using this medication could trigger a severe allergic reaction (like anaphylaxis), which can be life-threatening.

Tell your doctor about all your medical conditions, past and present, before starting Incruse Ellipta. This is crucial because certain conditions affect whether Incruse Ellipta is right for you. These conditions may include, but are not limited to:
• Acute Deterioration of COPD or Acute Symptoms: Incruse Ellipta is a maintenance treatment for COPD and should not be used as a rescue inhaler for sudden, severe breathing problems or during rapidly worsening COPD episodes.
• Narrow-Angle Glaucoma: Incruse Ellipta can worsen narrow-angle glaucoma. If you have this condition, your doctor should monitor you closely, and you should be aware of symptoms like eye pain, blurred vision, or seeing halos around lights.
• Paradoxical Bronchospasm: In rare cases, inhaling a bronchodilator can cause your airways to suddenly tighten instead of relaxing. If this happens immediately after using Incruse Ellipta, discontinue use and seek immediate medical attention.
• Urinary Retention: This medication can worsen urinary retention, especially in individuals with an enlarged prostate or bladder-neck obstruction. Be aware of symptoms like difficulty urinating, painful urination, or a weak urine stream.

Drug Interactions:

Before taking Incruse Ellipta, it is essential to discuss all potential risks and interactions with your doctor or pharmacist. For complete and up-to-date information, refer to the official Incruse Ellipta website: https://ca.gsk.com/media/6185/incruse_ellipta.pdf
• Other Anticholinergic Medications:
o Reason for Interaction: Incruse Ellipta itself is an anticholinergic. Taking it with other medications that also have anticholinergic effects can increase the risk and severity of anticholinergic side effects. These side effects include dry mouth, constipation, difficulty urinating (urinary retention), and blurred vision.
o Examples: Tiotropium (Spiriva), ipratropium (Atrovent HFA, in Combivent/DuoNeb), aclidinium (Tudorza Pressair), certain antihistamines (like diphenhydramine), some antidepressants (e.g., tricyclic antidepressants), certain medications for bladder problems (e.g., oxybutynin), and some medications for Parkinson's disease.

Pregnancy and Breastfeeding:

If you are pregnant, planning to become pregnant, or breastfeeding, it's crucial to discuss Incruse Ellipta with your doctor immediately. While animal studies haven't shown direct harm to a developing baby, there isn't enough reliable human data to fully understand its safety during pregnancy, so it's generally only used if the benefits to the mother outweigh any potential risks. Similarly, it's unknown if umeclidinium passes into breast milk, and therefore, a risk to a breastfed infant cannot be ruled out. Your doctor will help you weigh the importance of your treatment against any potential risks to your baby to decide the best course of action.

Use in Children:

Incruse Ellipta is generally not recommended in children or adolescents under 18. The safety and effectiveness of Incruse Ellipta in the pediatric population have not been established through adequate studies. COPD is also predominantly a disease affecting adults, particularly those with a history of smoking or exposure to lung irritants. Always consult your child’s doctor for the most appropriate and safest treatment.

Frequently Asked Questions about Incruse Ellipta at CanadaPharmacyOnline.com:

Why is Incruse Ellipta more affordable in Canada than in the United States?

Prescription drug prices, including Incruse Ellipta, are generally lower in Canada than in the US due to a combination of factors, primarily government price regulations, differing market dynamics, and other economic considerations. In Canada, provincial and federal governments negotiate drug prices with pharmaceutical companies, which often results in lower costs than the US, where market forces play a more significant role. For more information, see the FAQs on Prescription Drug Importation from the Kaiser Family Foundation (KFF): https://www.kff.org/health-costs/issue-brief/faqs-on-prescription-drug-importation/

How do I order from your pharmacy?

Ordering from us is very simple. You can purchase online or call Customer Service at 1866.920.3784; for more information or to learn about the ordering process, visit our How to Order page.

How much is the shipping?

Our shipping fee is a flat rate of $10.00 per order. Our pharmacy focuses on getting you the lowest prices on high-quality products.

Is there a limit on how many Incruse Ellipta I am allowed to order at one time?

CanadaPharmacyOnline.com can only dispense a maximum of a three-month supply of Incruse Ellipta at once, per your doctor's prescription.

Can I buy Incruse Ellipta over the counter from you?

No, Incruse Ellipta requires a valid prescription from your doctor. We do not sell this product without a valid prescription.

Do you ship to the United States?

Yes, we do. It usually takes 7 to 18 business days to receive your order from our pharmacy.

Is there a generic for Incruse Ellipta?

No, there is no generic alternative for this product.

Blog Post:

Ellipta for COPD or Asthma? What You Should Know

News:

A Guide to COPD: What To Expect Based on Your Age (article published on May 30, 2025)

Similar Drugs in the category of Asthma Medication/ Respiratory Disorders:

Flovent Inhaler Advair Symbicort Inhalation Aerosol Spiriva Caps and Device Albuterol

The information on this page is sourced from independent third parties contracted by CanadaPharmacyOnline. While we cannot guarantee its medical accuracy, we strongly recommend consulting a healthcare professional for personalized advice regarding medications or medical conditions.

Reviews From Real Customers